MORGAN STANLEY

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024			$8.00	1			$8.00^*	Q3 2024
9/30/2024	0%	0%	$4.5M	867K	-109,969	-11.3%	$5.19	Q3 2024
6/30/2024	0%	0%	$2.51M	977K	-226,808	-18.8%	$2.57	Q2 2024
3/31/2024			$7.00	1			$7.00^*	Q1 2024
3/31/2024	0%	+0%	$5.92M	1.2M	+324,654	+36.9%	$4.92	Q1 2024
12/31/2023	0%	+0%	$7.73M	879K	+277,054	+46%	$8.79	Q4 2023
9/30/2023	0%	0%	$6.91M	602K	-37,561	-5.87%	$11.47	Q3 2023
6/30/2023	0%	0%	$16.2M	640K	-94,220	-12.8%	$25.31	Q2 2023
3/31/2023	0%	0%	$23.6M	734K	-64,820	-8.11%	$32.21	Q1 2023
12/31/2022	0%	+0%	$14.7M	799K	+116,091	+17%	$18.46	Q4 2022
9/30/2022	0%	+0%	$18.4M	683K	+179,644	+35.7%	$27.00	Q3 2022
6/30/2022	0%	+0%	$6.95M	503K	+85,978	+20.6%	$13.82	Q2 2022
3/31/2022	0%	+0%	$8.13M	417K	+48,093	+13%	$19.50	Q1 2022
12/31/2021			$2K	96			$20.83^*	Q4 2021
12/31/2021	0%	+0%	$6.02M	369K	+86,381	+30.6%	$16.32	Q4 2021
9/30/2021	0%	0%	$7.87M	283K	-8,091	-2.78%	$27.86	Q3 2021
6/30/2021			$1K	23			$43.48^*	Q2 2021
6/30/2021	0%	+0%	$8.62M	291K	+122,144	+72.5%	$29.64	Q2 2021
3/31/2021			$1K	23			$43.48^*	Q1 2021
3/31/2021	0%	+0%	$4.71M	169K	+16,593	+10.9%	$27.94	Q1 2021
12/31/2020	0%	+0%	$4.31M	152K	+63,121	+71%	$28.35	Q4 2020
9/30/2020	0%	0%	$2.23M	88.8K	-10,371	-10.5%	$25.15	Q3 2020
6/30/2020	0%	+0%	$2.42M	99.2K	+67,656	+214%	$24.41	Q2 2020
3/31/2020			$1K	100			$10.00^*	Q1 2020
3/31/2020	0%	0%	$467K	31.6K	-58,231	-64.9%	$14.80	Q1 2020
12/31/2019			$2K	100			$20.00^*	Q4 2019
12/31/2019	0%	+0%	$1.46M	89.8K	+62,049	+224%	$16.23	Q4 2019
9/30/2019			$1K	100			$10.00^*	Q3 2019
9/30/2019	0%	+0%	$361K	27.7K	+21,771	+365%	$13.01	Q3 2019
6/30/2019			$1K	100			$10.00^*	Q2 2019
6/30/2019	0%	0%	$78K	5.97K	-102,148	-94.5%	$13.07	Q2 2019
3/31/2019			$2K	100			$20.00^*	Q1 2019
3/31/2019	0%	0%	$1.7M	108K	-45,130	-29.4%	$15.76	Q1 2019
12/31/2018	0%	0%	$3.08M	153K	-294	-0.19%	$20.12	Q4 2018
9/30/2018	0%	0%	$3.82M	154K	-29,219	-16%	$24.85	Q3 2018
6/30/2018	0%	+0%	$5.02M	183K	+12,358	+7.25%	$27.45	Q2 2018
3/31/2018	0%	0%	$5.25M	170K	-57,607	-25.3%	$30.80	Q1 2018
12/31/2017	0%	+0%	$8.15M	228K	+101,236	+79.9%	$35.75	Q4 2017
9/30/2017	0%	0%	$3.49M	127K	-52,319	-29.2%	$27.55	Q3 2017
6/30/2017	0%	+0%	$4.73M	179K	+25,421	+16.5%	$26.40	Q2 2017
3/31/2017	0%	0%	$3.2M	154K	-27,626	-15.2%	$20.80	Q1 2017
12/31/2016	0%	+0%	$3.75M	181K	+65,031	+55.9%	$20.70	Q4 2016
9/30/2016	0%	+0%	$1.88M	116K	+26,228	+29.1%	$16.20	Q3 2016
6/30/2016	0%	+0%	$1.23M	90K	+14,841	+19.7%	$13.61	Q2 2016
3/31/2016	0%	+0%	$1.31M	75.2K	+54,397	+262%	$17.45	Q1 2016
12/31/2015	0%	+0%	$711K	20.8K	+17,239	+484%	$34.18	Q4 2015
9/30/2015	0%	0%	$106K	3.56K	-55,860	-94%	$29.78	Q3 2015
6/30/2015	0%	+0%	$1.9M	59.4K	+52,373	+743%	$31.98	Q2 2015
3/31/2015	0%	+0%	$146K	7.05K	+506	+7.74%	$20.72	Q1 2015
12/31/2014	0%	+0%	$111K	6.54K	+635	+10.8%	$16.97	Q4 2014
9/30/2014	0%	+0%	$115K	5.91K	+1,393	+30.9%	$19.47	Q3 2014
6/30/2014	0%	0%	$154K	4.51K	-58,307	-92.8%	$34.12	Q2 2014
3/31/2014	0%	+0%	$1.98M	62.8K	+62,820	NEW	$31.50	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.